Search

Author/Creator Narendran, Aru

1. A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high‐grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study. Issue 11 (24th May 2017)

Authors:
Macy, Margaret E.; Kieran, Mark W.; Chi, Susan N.; Cohen, Kenneth J.; MacDonald, Tobey J.; Smith, Amy A.; Etzl, Michael M.; Kuei, Michele C.; Donson, Andrew M.; Gore, Lia; DiRenzo, Jennifer; Trippett, Tanya M.; Ostrovnaya, Irina; Narendran, Aru; Foreman, Nicholas K.; Dunkel, Ira J.
Journal:
Pediatric blood & cancer
Issue:
Volume 64:Issue 11(2017)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase 1 study of the CXCR4 antagonist plerixafor in combination with high‐dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10‐03). Issue 8 (14th April 2017)

Authors:
Cooper, Todd M.; Sison, Edward Allan Racela; Baker, Sharyn D.; Li, Lie; Ahmed, Amina; Trippett, Tanya; Gore, Lia; Macy, Margaret E.; Narendran, Aru; August, Keith; Absalon, Michael J.; Boklan, Jessica; Pollard, Jessica; Magoon, Daniel; Brown, Patrick A.
Journal:
Pediatric blood & cancer
Issue:
Volume 64:Issue 8(2017)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. ATRT-09. IDENTIFICATION OF POTENTIAL GENETIC DRIVERS OF METHOTREXATE (MTX) RESISTANCE IN ATYPICAL TERATOID RHABDOID TUMOURS (ATRT) THROUGH A GENOME-WIDE RNAI SCREEN. (1st June 2021)

Authors:
Kannappan, Sunand; Gupa, Mehul; Kang, SungMyung; Tran, Andy Son; Thakur, Satbir Singh; Jain, Mohit; Narendran, Aru
Journal:
Neuro-oncology
Issue:
Volume 23(2021)Supplement 1
Page Start:
i3
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy. Issue 6 (12th November 2014)

Authors:
Ruan, Yibing; Kovalchuk, Anna; Jayanthan, Aarthi; Lun, Xueqing; Nagashima, Yoji; Kovalchuk, Olga; Wright, James R.; Pinto, Alfredo; Kirton, Adam; Anderson, Ronald; Narendran, Aru
Journal:
Neuro-oncology
Issue:
Volume 17:Issue 6(2015:Jun.)
Page Start:
822
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. ETMR-08. INTERNATIONAL CONSENSUS PROTOCOL FOR EMBRYONAL TUMOR WITH MULTILAYER ROSETTES. (4th December 2020)

Authors:
Hanson, Derek; Andre, Nicolas; Chi, Susan; Filbin, Mariella; Fisher, Michael; Hoffman, Lindsey; Khatib, Ziad; Kool, Marcel; Narendran, Aru; Pizer, Barry; Slavc, Irene; Vogel, Timothy; Ziegler, David; Kieran, Mark
Journal:
Neuro-oncology
Issue:
Volume 22(2020)Supplement 3
Page Start:
iii324
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Identification and in vitro validation of neoantigens for immune activation against high-risk pediatric leukemia cells. Issue 12 (2nd December 2021)

Authors:
Thakur, Satbir; Jain, Mohit; Zhang, Chunfen; Major, Candice; Bielamowicz, Kevin J.; Lacayo, Norman J.; Vaske, Olena; Lewis, Victor; Murguia-Favela, Luis; Narendran, Aru
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 17:Issue 12(2021)
Page Start:
5558
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗